Vontobel Swiss Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$8.1M Buy
16,384
+1,486
+10% +$701K 4.16% 7
2021
Q1
$6.8M Buy
14,898
+1,652
+12% +$788K 3.79% 10
2020
Q4
$6.17M Sell
13,246
-304
-2% -$143K 3.51% 13
2020
Q3
$5.83M Sell
13,550
-2,581
-16% -$1.07M 4.07% 8
2020
Q2
$5.84M Buy
16,131
+1,889
+13% +$633K 3.84% 6
2020
Q1
$4.04M Buy
14,242
+287
+2% +$90.5K 3.08% 13
2019
Q4
$4.53M Buy
13,955
+2,401
+21% +$728K 2.96% 5
2019
Q3
$3.37M Sell
11,554
-665
-5% -$190K 2.17% 13
2019
Q2
$3.59M Sell
12,219
-153
-1% -$42.1K 1.92% 18
2019
Q1
$3.35M Buy
+12,372
New +$3.08M 3.63% 13

Other funds holding TMO

Vontobel Swiss Wealth Advisors's TMO Position: Q2 2021 in Review

Vontobel Swiss Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2021, buying an estimated $701K and bringing the position to 16,384 shares worth $8.1M. The position accounts for 4.16% of the portfolio, ranked #7.

Vontobel Swiss Wealth Advisors first reported a position in TMO in Q1 2019 and has held it in 10 quarters since. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Vontobel Swiss Wealth Advisors held 16,384 shares of Thermo Fisher Scientific worth $8.1M as of Q2 2021.
  • Vontobel Swiss Wealth Advisors bought 1,486 Thermo Fisher Scientific shares in Q2 2021, an estimated $701K.
  • Thermo Fisher Scientific made up 4.16% of Vontobel Swiss Wealth Advisors's portfolio in Q2 2021, its #7 holding.
  • Vontobel Swiss Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 10 quarters since.
  • 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.